Activity Stream
@moatrx
• 3 weeks ago
Posted a new blog:
UK POMPE DISEASE Competitive Intelligence
UK POMPE DISEASE Competitive Intelligence
Avalglucosidase alfa's NICE recommendation is settled, so NHS conversion speed, not cost-effectiveness, now gates the switch from alglucosidase alfa.
An estimated...



